Stylus Medicine, Inc. ("Stylus"), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today emerges from stealth with $85 million in financing. Stylus' funding ...

In today’s fast-paced biotechnology landscape, AMSA Biotech emerges as a trailblazer in the field of regenerative medicine. Driven by a vision of science-led healing and personalized care, the company ...

OFAB Ghana believes that cultivating interest in biotechnology among the youth is key to transforming Ghana’s agricultural ...

Trust of our neighbors is increasingly required to our shared human experience.

The global CRISPR Market, valued at US$2.90 billion in 2024, is forecasted to grow at a robust CAGR of 11.2%, reaching ...

According to the Ministry of Health (MoH), the Health Strategy and Policy Institute is working on a draft law and assessing ...

Bengaluru: Imagine performing surgery deep within the body using nanobots, assembling parts on a chip with high precision or ...

Artificial intelligence is gaining ground in healthcare, and tech's biggest players are racing to stake their claims.

Preconfigured applications: DRAGEN v4.4 will offer "push-button" analysis for oncology workflows, including the first and ...

Addressing the “ Centre for Genetic Engineering and Biotechnology” (ICGEB) Board Meeting of Governors here today, Dr.

NSF fellows are considered future knowledge experts who will go on to become lifelong leaders, innovators and teachers.